Walkner Condon Financial Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Walkner Condon Financial Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,516	Closed	-$243K	–	168
2021 Q1	$243K	Hold	1,516	–	–	0.09%	149
2020 Q4	$255K	Buy	1,516 +65	+4%	+$10.5K	0.11%	114
2020 Q3	$228K	Buy	1,451 +41	+3%	+$6.7K	0.12%	111
2020 Q2	$237K	Sell	1,410 -215	-13%	-$33.7K	0.21%	52
2020 Q1	$213K	Hold	1,625	–	–	0.23%	49
2019 Q4	$242K	Buy	+1,625	New	+$223K	0.23%	59

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Walkner Condon Financial Advisors's FBT Position: Q2 2021 in Review

Walkner Condon Financial Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2021, closing a stake of 1,516 shares — an estimated $243K sold.

Walkner Condon Financial Advisors first reported a position in FBT in Q4 2019 and held it in 6 quarters. The position peaked at $255K in Q4 2020. 233 funds tracked by Wall St. Rank hold FBT as of Q2 2021.

Walkner Condon Financial Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2021 after selling out during the quarter.
Walkner Condon Financial Advisors sold 1,516 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2021, an estimated $243K.
Walkner Condon Financial Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and held it in 6 quarters.
Walkner Condon Financial Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $255K in Q4 2020.
233 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2021.

Based on Walkner Condon Financial Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.